Ecolab to Collaborate with AvidBiotics to Develop New
Technology Targeting Food Safety in Meat
Companies agree to collaborate on protein platform targeting E. coli O157:H7 contamination in red meat
January 26, 2010 08:33 AM Eastern Time
ST. PAUL, Minn.--(EON: Enhanced Online News)--Ecolab Inc. has entered into an agreement with AvidBiotics Corp. under whic
work to develop a new technology that could significantly reduce the presence of the pathogen E. coli O157:H7 in red meat produ
The companies’ intent is to successfully commercialize AvidBiotics’ proprietary protein-based antibacterial technology, which can b
specific bacterial pathogens. While this platform technology may be applicable to numerous food pathogens, the companies are first
pathogen E. coli in red meat. According to the U.S. Centers for Disease Control and Prevention (CDC), over 70,000 people are i
coli each year in the United States, at least 2,000 are hospitalized, and approximately 60 die as a direct result of E. coli infection an
complications.
Timothy Mulhere, Ecolab’s senior vice president and general manager for Food & Beverage North America, commented, saying, “
committed to helping customers reduce their food safety risks, offering multiple interventions to help ensure a safer global food suppl
with AvidBiotics to further develop this platform technology to complement and further strengthen our industry-leading suite of antim
safety solutions for the food processing market.”
About Ecolab
With sales of $6 billion and more than 26,000 associates, Ecolab Inc. (NYSE: ECL) is the global leader in cleaning, sanitizing, food
infection prevention products and services. Ecolab delivers comprehensive programs and services to foodservice, food and beverag
healthcare, and hospitality markets in more than 160 countries. More news and information is available at www.ecolab.com.
About AvidBiotics
AvidBiotics Corp. is a biotherapeutics company with a proprietary technology platform focused on the development of protein prod
bacteri